How fluid flow through the body can affect the ways in which antibiotics work.

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.

Rumours claim that a well-known vaccine skeptic has been appointed to lead study on links between vaccines and autism.

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.